Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events european society medical oncology esmo 43rd congress
… of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… 12, 2022 Most of what we know about treatments, adverse events, and the overall survival of patients with chronic … events and survival) and financial outcomes (direct medical costs to both patients and the healthcare system). … presented at the 61st Annual Meeting of the American Society of Hematology; December 2019. Orlando, FL. [abstract] …
… Submission Requirements of Nordic HTA Organizations for Medical Technologies Maria Kinderås, MSc Senior Associate, … for a while, HTA organizations have in recent years taken medical technologies under their wings as well. Nordic … of Nordic health technology assessment organisations for medical technologies: results of an online survey . Poster …
… and Similarities of Health Economic Evaluation for Medical Technologies by HTA Bodies Vijay D'Souza, PhD Senior … Transcript In recent years, an increasing number of medical technologies such as devices, diagnostics, and … and similarities of health economic evaluation for medical technologies by HTA bodies . Poster presented at the …
Thirteenth Annual FDA Sentinel Initiative Public Workshop Share on: Monday, November 8, 2021, 10am - Tuesday, November 9, 2021, 2pm Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
… (NASEM) will conduct a study in the United States and the European Union on the processes used to evaluate the safety … of Drugs for Rare Diseases in the United States and the European Union Meeting #3 (Virtual): 6-7 February 2024 …
… Emergence of the Joint Clinical Assessment in the European Union Anne Heyes, MBA Vice President, Head of Value … (HTAR) is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as cell and gene therapies), and medical technologies. Therapies for rare diseases will be …
… thought leadership from our experts, and receive periodic news and updates. Fill out the form below to sign up. By …
… for the new Medicare Drug Price Negotiation Program. The European regulation on health technology assessment is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as cell and gene therapies), and medical technologies. Therapies for rare diseases will be …